Best thing about my Dickinson experience so far: "One of the highlights of my time at Dickinson has been working in Associate ...

Celebrities have sent prostate cancer’s public profile soaring in recent years. But with accusations that some men are being harmed by over-testing, while those at highest risk are missing out on life ...

Know how the day will unfold for all 12 zodiac signs, including love, career, finances, health, lucky colour and lucky number.

Nikola Topic has made his NBA debut for the Oklahoma City Thunder four months after he was diagnosed with testicular cancer. Topic, 20, returned to the court on Thursday, February 12, for the ...

Oklahoma City coach Mark Daigneault said he was "incredibly happy" after the NBA prospect made his return Sean Neumann has more than a decade of experience working as a reporter, with a focus on ...

OKLAHOMA CITY — Oklahoma City Thunder prospect Nikola Topic has made his NBA G League debut after recovering from a major knee injury and undergoing cancer treatment. Topic had seven points and seven ...

Moving over to the right-wing spot, Nikola Topic received Isaiah Joe's last-hope pass. He calmly swished in the catch-and-shoot look despite Terance Mann's textbook contest. In just his second NBA ...

Longtime friends and allies of Joe Biden say they are worried about the toll an aggressive form of prostate cancer is taking on the former president and his health. But Biden and his aides say he is ...

OKLAHOMA CITY (AP) — Oklahoma City Thunder prospect Nikola Topic has made his NBA G League debut after recovering from a major knee injury and undergoing cancer treatment. Topic had seven points and ...

The two-year project is designed to help dental health providers normalize HPV vaccine discussions and reduce oropharyngeal cancer risk. A $100,000 grant fro ...

Nikola Topic, an Oklahoma City Thunder first-round pick in the 2024 NBA Draft, made his debut in the G League Monday night as he returned from fighting testicular cancer. The 12th overall pick in that ...

The idea that cancer treatment might work better at certain times of day has circulated for decades but has rarely faced rigorous clinical testing. Now, a randomized trial of 210 people with advanced ...